Rankings
▼
Calendar
RCUS FY 2020 Earnings — Arcus Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RCUS
Arcus Biosciences, Inc.
$2B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$78M
+420.0% YoY
Gross Profit
$78M
100.0% margin
Operating Income
-$124M
-159.0% margin
Net Income
-$123M
-157.7% margin
EPS (Diluted)
$-2.13
Cash Flow
Operating Cash Flow
$111M
Free Cash Flow
$108M
Stock-Based Comp.
$22M
Balance Sheet
Total Assets
$772M
Total Liabilities
$270M
Stockholders' Equity
$502M
Cash & Equivalents
$173M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$78M
$15M
+420.0%
Gross Profit
$78M
$15M
+420.0%
Operating Income
-$124M
-$89M
-39.8%
Net Income
-$123M
-$85M
-45.2%
← Q4 2019
All Quarters
Q1 2020 →